42135 10th St W Ste 201
Lancaster, CA 93534-6093
(661) 341-3800
Mon-Fri: 8:00 am - 8:00 pm
Sat: 8:00 am - 5: 00 pm
Familyfirst Urgent Care offers solutions to reduce the obesity impacting all generations today.
Obesity is a multifaceted chronic disease that is increasingly affecting children, adolescents, and adults. In the United States, the prevalence of obesity has doubled among children and tripled among adolescents since 1980. Currently, approximately 19.7% of children aged 2 to 19 are classified as obese, while the figure rises to over 41% among adults. The ramifications of this trend are profound, with health care professionals noting a surge in the early onset of type 2 diabetes, cardiovascular diseases, and mental health issues such as depression and social isolation among the younger population.
The urgency of addressing obesity in childhood stems from the heightened risk of these conditions persisting into adulthood, with each advancing year of age compounding the likelihood. Consequently, this elevates the individual’s risk for chronic conditions like diabetes, hypertension, and heart disease.
Our Familyfirst Urgent Care weight loss clinics can help you reach a healthy weight.
Peptides are short chains of amino acids, the building blocks of proteins. In the human body, they serve various functions. Peptides can act as signaling molecules, transmitting messages between cells and regulating biological processes. They are involved in metabolism, immune response, and tissue repair, among other vital functions. Some peptides are FDA approved for the treatment of certain diseases. Other peptides used clinically are prepared by an FDA registered cGMP sterile laboratory complying with all state and federal laws. Peptides can be administered in various presentations, including but not limited to oral, intravenous, subcutaneous, intramuscular and intranasal routes.
Prolonged shortages of popular new weight loss drugs including Zepbound and Wegovy are causing frustrations for patients, pharmacists and medical providers, and there’s no immediate relief in sight. Compounding pharmacies are authorized to produce equivalents of FDA-approved medications during drug shortages. This practice is supported by the FDA, particularly when the active ingredients are included on the agency’s drug shortage list. Semaglutide and tirzepatide, the active components in the widely-used weight loss medications Wegovy and Zepbound, have been subject to such shortages. The FDA’s endorsement of compounding pharmacies’ efforts helps ensure continued access to these important drugs when supply is limited.
SEMAGLUTIDE: ONCE A WEEK INJECTION
GLP-1 receptor agonists, particularly Semaglutide, are heralded as a revolutionary breakthrough in the fight against obesity, marking a new era in hormonal treatment strategies. Esteemed experts in the field have lauded these medications as a “game-changer” in obesity medicine, underscoring their significant impact on health management.
Semaglutide, a prominent member of the GLP-1 receptor agonist class, has received FDA approval for its efficacy in managing type 2 diabetes and facilitating weight loss in adults seeking to reduce their body weight. This endorsement reflects the growing confidence in GLP-1 based therapies as a transformative approach to weight management and diabetes care.
It’s important to note that while GLP-1 medications like Semaglutide offer substantial benefits, they are most effective when combined with lifestyle changes such as diet and exercise4. Moreover, the medical community is actively researching and developing new GLP-1 drugs that promise to extend health benefits beyond weight loss, potentially improving liver and heart function while minimizing side effects.
In the United States, nearly 70% of adults are grappling with obesity or overweight conditions, which are significant contributors to some of the leading causes of mortality, including heart disease. One potential avenue for weight management is the prescription medication Ozempic, known generically as semaglutide, a GLP-1 analog. Suitable candidates may receive this medication as a once-weekly injection that emulates the body’s natural hormones, promoting a sense of satiety sooner and sustaining it for a longer duration.
Despite earnest efforts—such as calorie restriction, increased physical activity, and various dieting approaches—many find sustained weight loss to be an elusive goal. Often, initial success is followed by a relapse to the starting point.
Nonetheless, even a modest weight reduction of 5% to 10% through diet and exercise has been shown to significantly decrease the risk of cardiovascular diseases in adults with obesity or overweight. However, achieving this can be challenging for some.
At Familyfirst Urgent Care, , Semaglutide Injections are administered with the utmost care by our premier medical experts across all locations. During a complimentary consultation, our skilled team will evaluate your eligibility for our managed weight loss program that includes Semaglutide Injections, ensuring a personalized approach to your health journey.
What is included in our packages:
Visit Family First Family Medical Practice by clicking on the following link www.familyfirstmedgroup.com
To learn more about our providers, click on the following link below:
https://www.familyfirstmedgroup.com/providers
We are currently open to new patients.
We take same day walkings or schedule three days in advance by calling 661-341-3800.